Actuate Therapeutics, Inc. (ACTU) — S-1/A Filings
All S-1/A filings from Actuate Therapeutics, Inc.. Browse 5 S-1/A reports with AI-powered summaries and risk analysis.
S-1/A Filings (5)
-
Actuate Therapeutics Files IPO Amendment
— Jul 23, 2024 Risk: medium
Actuate Therapeutics, Inc. filed an S-1/A amendment on July 23, 2024, for its initial public offering. The company, formerly known as Apotheca Therapeutics, Inc -
Actuate Therapeutics Files S-1/A Amendment
— Jul 19, 2024 Risk: medium
Actuate Therapeutics, Inc. filed an S-1/A amendment on July 19, 2024, for its registration statement. The company, formerly known as Apotheca Therapeutics, Inc. -
Actuate Therapeutics Files S-1/A for IPO
— Jul 16, 2024 Risk: medium
Actuate Therapeutics, Inc. filed an S-1/A amendment on July 16, 2024, for its initial public offering. The company, formerly known as Apotheca Therapeutics, Inc -
Actuate Therapeutics Files S-1/A for IPO
— Jun 21, 2024 Risk: medium
Actuate Therapeutics, Inc. filed an S-1/A amendment on June 21, 2024, for its initial public offering. The company, formerly known as Apotheca Therapeutics, Inc -
Actuate Therapeutics Files S-1/A Amendment
— Jun 11, 2024 Risk: medium
Actuate Therapeutics, Inc. filed an S-1/A amendment on June 11, 2024, for its registration statement. The company, formerly known as Apotheca Therapeutics, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX